Panic control treatment for agoraphobia

Area of Science:

• Psychology
• Clinical Psychology
• Anxiety Disorders

Background:

• Panic disorder with agoraphobia is a debilitating condition.
• Cognitive-behavioral therapy (CBT) is a leading treatment approach.
• The role of in vivo exposure in addition to CBT for panic disorder with agoraphobia requires further investigation.

Purpose of the Study:

• To compare the efficacy of CBT for panic control alone versus CBT with an added in vivo exposure component.
• To determine if in vivo exposure enhances treatment outcomes for panic disorder and agoraphobia.
• To explore the relationship between panic frequency reduction and agoraphobic avoidance reduction.

Main Methods:

• Randomized controlled trial with 68 participants diagnosed with panic disorder with agoraphobia.
• Two 16-week treatment conditions: panic control only and panic control with in vivo exposure.
• Assessments conducted at baseline, mid-treatment, posttreatment, and 6-month follow-up using diagnostic and behavioral measures.

Main Results:

• Both treatment conditions demonstrated equal efficacy in treating panic disorder and agoraphobia.
• The addition of in vivo exposure did not yield superior results compared to panic control alone.
• A decrease in panic frequency was a significant predictor of reduced agoraphobic avoidance.

Conclusions:

• Cognitive-behavioral treatment for panic control is effective for panic disorder with agoraphobia, even without a specific in vivo exposure component.
• In vivo exposure targeting agoraphobia may be redundant when panic control is effectively addressed.
• Future research should focus on the mechanisms underlying panic reduction and its impact on avoidance behaviors.